 |
Kenneth B. Gordon, MD Associate Professor of Dermatology Northwestern University Feinberg School of Medicine Head, Division of Dermatology Evanston Northwestern Healthcare Skokie, Illinois |
Kenneth B. Gordon received a medical degree from Columbia University in New York. He completed an internship and residency in internal medicine at Beth Israel Hospital/Harvard University in Boston, Massachusetts and a clinical residency in dermatology at Northwestern University in Chicago, Illinois. He worked as a postdoctoral fellow at Northwestern University, jointly sponsored by the Departments of Dermatology and Microbiology/Immunology. He currently serves as the Head of the Division of Dermatology at Evanston Northwestern Healthcare in Illinois and is an Associate Professor of Dermatology at the Northwestern University Feinberg School of Medicine.
Board certified in dermatology, Dr. Gordon has received several awards and honors, including the Society for Investigative Dermatology’s Albert Klingman Fellowship and the Dermatology Foundation Clinical Career Development Award. He was recently named as one of the "Best Doctors in America" and is listed in Who’s Who in Medicine and Healthcare.
Dr. Gordon has published numerous articles and book chapters, and given many presentations, on topics relating to the treatment of psoriasis, atopic dermatitis, and nonmelanoma skin cancer. He is on the Editorial Board of the Journal of the American Academy of Dermatology and is an ad hoc reviewer for Archives of Dermatology, British Journal of Dermatology, The Journal of Investigative Dermatology, and The Journal of the American Medical Association.
 |
Jeffrey J Crowley, MD Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California Assistant Clinical Professor Department of Medicine University of California Los Angeles, California |
Jeffrey J. Crowley, received a medical degree and completed a medical internship and dermatology residency at Stanford University in California. Dr. Crowley is currently in private practice with the Bakersfield Dermatology & Skin Cancer Medical Group in Bakersfield, California, which provides comprehensive therapy of psoriasis including biologics, systemic, phototherapy, and clinical trials of new therapeutic modalities.
Board certified in dermatology, Dr. Crowley holds membership in the American Medical Association, the California Medical Association, and the Kern County Medical Association, for which he has served on the board of directors. He is a Fellow of the American Academy of Dermatology, theAmerican Society of Dermatologic Surgery, and the American Society of Mohs Surgery. He serves on the board of directors and as Secretary-Treasurer of CalDerm (California Society of Dermatology and Dermatologic Surgery).
Dr. Crowley has published on such topics as the effect of tumor necrosis factor on neutrophil function, cutaneous T-cell lymphoma, and the treatment of psoriasis. His academic interests including teaching dermatology and family practice residents at both Stanford University (Clinical Instructor) and the University of California, Los Angeles (Clinical Assistant Professor). Dr. Crowley has been involved in phase 2, 3, and postmarketing studies with alefacept, etanercept, efalizumab, adalimumab, and other investigational agents.